Cargando…

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

Remdesivir is a broad-spectrum antiviral nucleotide prodrug that has been clinically evaluated in Ebola virus patients and recently received emergency use authorization (EUA) for treatment of COVID-19. With approvals from the Federal Select Agent Program and the Centers for Disease Control and Preve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo, Michael K., Albariño, César G., Perry, Jason K., Chang, Silvia, Tchesnokov, Egor P., Guerrero, Lisa, Chakrabarti, Ayan, Shrivastava-Ranjan, Punya, Chatterjee, Payel, McMullan, Laura K., Martin, Ross, Jordan, Robert, Götte, Matthias, Montgomery, Joel M., Nichol, Stuart T., Flint, Mike, Porter, Danielle, Spiropoulou, Christina F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2020
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604432/ https://www.ncbi.nlm.nih.gov/pubmed/33028676 http://dx.doi.org/10.1073/pnas.2012294117

Ejemplares similares

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2018)

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2016)

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
por: Tchesnokov, Egor P., et al.
Publicado: (2019)

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
por: Flint, Mike, et al.
Publicado: (2019)

Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
por: Lo, Michael K., et al.
Publicado: (2021)

Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2020)

Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)
por: Lo, Michael K., et al.
Publicado: (2021)

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
por: Lo, Michael K., et al.
Publicado: (2017)

Complete Genome Sequences of a Hantavirus Isolate from New York
por: McMullan, L. K., et al.
Publicado: (2018)

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
por: Gordon, Calvin J., et al.
Publicado: (2020)

Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus
por: Tchesnokov, Egor P., et al.
Publicado: (2018)

Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin
por: Bergeron, Éric, et al.
Publicado: (2015)

Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
por: Tchesnokov, Egor P., et al.
Publicado: (2020)

Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
por: Tchesnokov, Egor P., et al.
Publicado: (2021)

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
por: Gordon, Calvin J., et al.
Publicado: (2020)

Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir
por: Gordon, Calvin J., et al.
Publicado: (2021)

Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses
por: Albariño, César G., et al.
Publicado: (2018)

Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compounds
por: Welch, Stephen R., et al.
Publicado: (2018)

646. Activated Macrophages as Pathogenesis Factors in Ebola Virus Disease in Humans
por: McElroy, Anita, et al.
Publicado: (2018)

Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs
por: Maheden, Kieran, et al.
Publicado: (2021)

Utility of Oral Swab Sampling for Ebola Virus Detection in Guinea Pig Model
por: Spengler, Jessica R., et al.
Publicado: (2015)

Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform
por: Welch, Stephen R., et al.
Publicado: (2021)

Complete Genome Sequences of Monongahela Hantavirus from Pennsylvania, USA
por: Albariño, César G., et al.
Publicado: (2018)

Severe Hemorrhagic Fever in Strain 13/N Guinea Pigs Infected with Lujo Virus
por: Bird, Brian H., et al.
Publicado: (2012)

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans
por: McElroy, Anita K., et al.
Publicado: (2019)

Clinical trials in an Ebola outbreak seek to find an evidence-based cure
por: McMullan, Laura K.
Publicado: (2020)

Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses()
por: Albariño, César G., et al.
Publicado: (2014)

The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor
por: Todd, Brendan, et al.
Publicado: (2021)

Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
por: Warren, Travis K., et al.
Publicado: (2021)

Insights into Reston virus spillovers and adaption from virus whole genome sequences
por: Albariño, César G., et al.
Publicado: (2017)

Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021)

Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
por: Stevens, Laura J., et al.
Publicado: (2022)

The journey of remdesivir: from Ebola to COVID-19
por: Pardo, Joe, et al.
Publicado: (2020)

Remdesivir : d’Ebola à la Covid ?
por: Dalmat, Yann-Mickael
Publicado: (2021)

Reemerging Sudan Ebola Virus Disease in Uganda, 2011
por: Shoemaker, Trevor, et al.
Publicado: (2012)

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model
por: Welch, Stephen R., et al.
Publicado: (2018)

Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
por: McElroy, Anita K., et al.
Publicado: (2014)

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
por: Gordon, Calvin J., et al.
Publicado: (2021)

Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
por: Yan, Victoria C., et al.
Publicado: (2021)

The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
por: Feng, Joy Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_99dpb1pq2f0jeiihm22g7kdag7